Study of Quality of Life for Prostate Proton Therapy
NCT00489814 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1125
Last updated 2020-01-07
Summary
The goal of this research study is to collect information on the side effects of proton radiation therapy given for the treatment of prostate cancer as well as the effect of proton therapy on quality of life. Information on your treatment and how you react to the treatment will be collected. Researchers will use this information to try to understand how people tolerate proton radiation therapy for prostate cancer.
Conditions
Interventions
- BEHAVIORAL
-
Questionnaire
Questionnaires administered within 3 weeks before the beginning of the radiation treatment course, twice during radiation therapy, and upon completion of radiation therapy.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Seungtaek Choi, MD · M.D. Anderson Cancer Center
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-24
- Primary Completion
- 2020-05-24
- Completion
- 2020-05-24
Countries
- United States
Study Locations
More Related Trials
-
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
NCT01950351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT01059513 ·Status: COMPLETED
-
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
NCT00850941 ·Status: UNKNOWN
-
Assessing Quality of Life of Patients With Prostate Cancer
NCT00041301 ·Status: COMPLETED
-
HRQOL in Prostate Cancer Patients Treated With Radiotherapy
NCT05645237 ·Status: ACTIVE_NOT_RECRUITING
-
Prostate Cancer Parameters for Patients Receiving Proton Treatment
NCT02110849 ·Status: WITHDRAWN
-
Internal Radiation Therapy in Treating Patients With Prostate Cancer
NCT00573833 ·Status: COMPLETED ·Phase: NA
-
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
NCT00831623 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Embolization and Cytoreduction in Prostate Cancer
NCT07251829 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
NCT05454488 ·Status: RECRUITING ·Phase: PHASE2
-
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
NCT05038332 ·Status: RECRUITING ·Phase: PHASE2
-
Proton Therapy for Low and Intermediate Risk Prostate Cancer
NCT00693238 ·Status: COMPLETED ·Phase: NA
-
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
NCT01492972 ·Status: RECRUITING ·Phase: PHASE3
-
MRI in Diagnosing Prostate Cancer
NCT01292291 ·Status: UNKNOWN ·Phase: NA
-
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT01617161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Protons Vs. Photons for High-risk Prostate Cancer
NCT05350475 ·Status: RECRUITING ·Phase: NA
-
Outcomes of Focal Ablation for Prostate Cancer
NCT05478694 ·Status: RECRUITING
-
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NCT04725903 ·Status: RECRUITING ·Phase: NA
-
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
NCT05880446 ·Status: COMPLETED ·Phase: NA
-
Ultra-hypofractionated Radiation in Prostate Cancer
NCT03486821 ·Status: COMPLETED ·Phase: NA
-
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
NCT01686958 ·Status: COMPLETED ·Phase: NA
-
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
NCT03987386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NCT00969111 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
NCT02040610 ·Status: RECRUITING ·Phase: NA